/

/

Psychedelics Policy Is Shifting In Washington: Here's What One Biotech CEO Sees Coming - Cybin...

Tue, Jun 3

Perspectives

Psychedelics have hit the government's radar in a big way 🧠🇺🇸 FDA calls it a “top priority.” Texas funds $50M in ibogaine trials. HHS hires a psychedelics czar. @CybinInc $CYBN CEO @insidepharma tells @Benzinga what’s coming next: https://t.co/CkOzy4Tb97

14607

Federal support for psychedelics is rising fast. One biotech CEO explains what it means for clinical trials, access, and real-world therapy.

Discover